The Claim
Oxidized eicosapentaenoic acid (EPA) has no effect on the expression of constitutive endothelial markers endoglin and HLA class I, and its anti-inflammatory effect is restricted to inducible adhesion molecules without causing general endothelial suppression.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Oxidized EPA does not change the levels of baseline endothelial markers endoglin and HLA class I, meaning its anti-inflammatory action targets only induced adhesion molecules and does not broadly suppress endothelial function.
See the scientific wording
Oxidized eicosapentaenoic acid (EPA) does not affect the expression of constitutive endothelial markers endoglin and HLA class I, indicating its anti-inflammatory effect is specific to inducible adhesion molecules rather than general endothelial suppression.
When EPA is oxidized, it enters endothelial cells and turns on a protein called PPARα, which blocks a signaling molecule called NF-κB from turning on genes for sticky proteins that attract white blood cells. This only affects the sticky proteins that appear during inflammation, not the normal proteins always present on the cell surface.
What the research says
1 studyThe study measured multiple endothelial surface proteins and found oxidized EPA only reduced inflammation-induced molecules (ICAM-1, VCAM-1, E-selectin), not constitutive ones (endoglin, HLA-I), supporting specificity of action.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.